Skip to main content

Bernie Monegain

Bernie Monegain

Bernie Monegain is the former Editor-At-Large for Healthcare IT News and Women in Health IT.

By Bernie Monegain | 10:33 am | August 16, 2016
The network now conducts more transactions daily than Amazon or Uber, according to CEO Tom Skelton.
By Bernie Monegain | 09:01 am | August 16, 2016
The framework will make interoperability work happening today widespread as more and more EHR vendors, HIEs and providers join the network, according to an Epic executive.
By Bernie Monegain | 10:56 am | August 12, 2016
Twenty one hospitals will use the supercomputer and the Watson for Oncology software piloted by Memorial Sloan Kettering in New York to offer personalized care for cancer patients.
By Bernie Monegain | 12:53 pm | August 11, 2016
The remainder of the 100 wealthiest technology leaders worldwide are men.
By Bernie Monegain | 11:21 am | August 11, 2016
The startup’s technology platform combines data science with analytics, clinical expertise, mobile tools to create personalization and engagement, CEO Rajeev Singh said.
By Bernie Monegain | 10:29 am | August 10, 2016
The diagnostic and imaging company will use the funding to advance development of technology for testing blood supplies for the Zika virus.
By Bernie Monegain | 11:03 am | August 09, 2016
Doctors at the National Human Genome Research Institute, the National Cancer Institute and the NIH Clinical Center will use the tools to combine genomic and clinical data for statistical analysis and pattern detection.
By Bernie Monegain | 11:58 am | August 08, 2016
The supercomputer identified a different type of cancer than the one doctors were currently treating for a patient in Japan.
By Bernie Monegain | 08:15 am | August 08, 2016
Healthcare IT News traveled to Epic's Verona, Wisconsin, campus and met with the company's elusive founder, as well as with Epic Vice President Peter DeVault. The two talked a lot about interoperability – but perhaps not enough to quell critics.
By Bernie Monegain | 10:40 am | August 04, 2016
The company also said its scientists are working with Icahn School of Medicine at Mount Sinai to test the technology on prostate cancer.